Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod: A Single Arm, Open Label Prospective Cohort Study

NCT06860633 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT06860633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06860633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod: A Single Arm, Open Label Prospective Cohort Study
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Recruiting
Start date
March 6, 2025
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

achr myasthenia gravis, myasthenia gravis crisis, myasthenia gravis exacerbations